Issue 9, 2011

Enantioselective preparation of ferrocenyl amino phosphines and their cytotoxic activities

Abstract

In connection to our previously reported phosphine compounds as antitumor agents, this article describes the preparation of ferrocenyl amino-phosphine and their possible cytotoxic potential towards the human hepatocellular carcinoma cell line Hep3B. The preliminary results suggested that ferrocenyl amino-phosphines can be potential anti-tumour agents which might be considered as novel cancer chemotherapeutic agents. In particular, compounds 4b, 4d and 4f exhibit strong cytotoxicity with IC50 < 5 μg ml−1. These compounds possess more promising cytotoxic activities than their precursor non-substituted ferrocene as well as the reference metallodrug cisplatin.

Graphical abstract: Enantioselective preparation of ferrocenyl amino phosphines and their cytotoxic activities

Article information

Article type
Concise Article
Submitted
07 Jan 2011
Accepted
17 Jun 2011
First published
21 Jul 2011

Med. Chem. Commun., 2011,2, 881-885

Enantioselective preparation of ferrocenyl amino phosphines and their cytotoxic activities

S. H. Kok, W. Lam, A. S. Chan, W. Wong, R. Gambari, R. S. Wong, K. K. Lee, J. C. Tang, K. Lam and C. Chui, Med. Chem. Commun., 2011, 2, 881 DOI: 10.1039/C1MD00005E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements